NSPR logo

InspireMD (NSPR) Return On Equity

Annual ROE

-70.01%
+2.61%+3.59%

December 31, 2023


Summary


Performance

NSPR ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNSPRprofitabilitymetrics:

Quarterly ROE

-68.55%
-8.19%-13.57%

September 30, 2024


Summary


Performance

NSPR Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNSPRprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

NSPR ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3.6%-1.1%
3 y3 years+41.8%-35.7%
5 y5 years+44.5%+46.4%

NSPR ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-7.2%+3.6%-57.0%+18.8%
5 y5-year-7.2%+50.7%-57.0%+56.5%
alltimeall time-106.7%+95.5%-101.0%+99.1%

InspireMD ROE History

DateAnnualQuarterly
Sep 2024
-
-68.55%(+13.6%)
Jun 2024
-
-60.36%(-5.3%)
Mar 2024
-
-63.71%(+2.6%)
Dec 2023
-70.01%(-3.6%)
-62.09%(-8.4%)
Sep 2023
-
-67.79%(-9.2%)
Jun 2023
-
-74.68%(-11.6%)
Mar 2023
-
-84.46%(+17.2%)
Dec 2022
-72.62%(+11.2%)
-72.09%(+20.2%)
Sep 2022
-
-59.98%(+15.8%)
Jun 2022
-
-51.79%(+18.6%)
Mar 2022
-
-43.65%(-2.0%)
Dec 2021
-65.29%(-45.7%)
-44.52%(-11.8%)
Sep 2021
-
-50.50%(-4.4%)
Jun 2021
-
-52.85%(-24.7%)
Mar 2021
-
-70.22%(-39.4%)
Dec 2020
-120.19%(-15.3%)
-115.82%(+3.3%)
Sep 2020
-
-112.10%(-12.3%)
Jun 2020
-
-127.80%(-18.9%)
Mar 2020
-
-157.51%(+4.3%)
Dec 2019
-141.95%(+12.6%)
-150.95%(+20.9%)
Sep 2019
-
-124.87%(-9.2%)
Jun 2019
-
-137.57%(+4.1%)
Mar 2019
-
-132.11%(+0.7%)
Dec 2018
-126.02%(-49.4%)
-131.24%(-9.1%)
Sep 2018
-
-144.37%(-23.9%)
Jun 2018
-
-189.78%(-3.6%)
Mar 2018
-
-196.79%(+12.0%)
Dec 2017
-249.20%(-83.8%)
-175.73%(+5.0%)
Sep 2017
-
-167.35%(-31.6%)
Jun 2017
-
-244.58%(-47.0%)
Mar 2017
-
-461.52%(-75.7%)
DateAnnualQuarterly
Dec 2016
-1539.76%(-391.1%)
-1896.02%(-372.8%)
Sep 2016
-
695.12%(+95.1%)
Jun 2016
-
356.20%(-104.8%)
Mar 2016
-
-7461.58%(+39.2%)
Dec 2015
529.02%(-161.7%)
-5359.35%(+236.5%)
Sep 2015
-
-1592.82%(-127.1%)
Jun 2015
-
5872.07%(+296.9%)
Mar 2015
-
1479.57%(-154.9%)
Dec 2014
-857.66%(+1036.4%)
-2694.91%(+423.3%)
Sep 2014
-
-514.97%(-15.7%)
Jun 2014
-
-611.21%(+21.3%)
Mar 2014
-
-503.74%(-1.4%)
Dec 2013
-75.47%(-72.3%)
-
Sep 2013
-
-510.77%(-40.8%)
Jun 2013
-
-863.12%(-24.8%)
Jun 2013
-272.32%(+133.4%)
-
Mar 2013
-
-1147.94%(+112.1%)
Dec 2012
-
-541.11%(+33.9%)
Sep 2012
-
-404.24%(+76.1%)
Jun 2012
-116.66%(-73.1%)
-
Mar 2012
-
-229.55%(-6.6%)
Dec 2011
-434.41%(-141.6%)
-245.70%(+120.4%)
Sep 2011
-
-111.47%(-0.3%)
Jun 2011
-
-111.84%(+12.6%)
Mar 2011
-
-99.34%(-112.1%)
Dec 2010
-
818.35%(-87.8%)
Sep 2010
-
6720.00%(-982.0%)
Jun 2010
1043.48%(-566.8%)
-761.90%(+195.0%)
Mar 2010
-
-258.25%(-54.3%)
Dec 2009
-
-564.71%(+39.1%)
Sep 2009
-
-405.88%(+2199.6%)
Jun 2009
-223.53%
-17.65%

FAQ

  • What is InspireMD annual return on equity?
  • What is the all time high annual ROE for InspireMD?
  • What is InspireMD annual ROE year-on-year change?
  • What is InspireMD quarterly return on equity?
  • What is the all time high quarterly ROE for InspireMD?
  • What is InspireMD quarterly ROE year-on-year change?

What is InspireMD annual return on equity?

The current annual ROE of NSPR is -70.01%

What is the all time high annual ROE for InspireMD?

InspireMD all-time high annual return on equity is 1043.48%

What is InspireMD annual ROE year-on-year change?

Over the past year, NSPR annual return on equity has changed by +2.61% (+3.59%)

What is InspireMD quarterly return on equity?

The current quarterly ROE of NSPR is -68.55%

What is the all time high quarterly ROE for InspireMD?

InspireMD all-time high quarterly return on equity is 6720.00%

What is InspireMD quarterly ROE year-on-year change?

Over the past year, NSPR quarterly return on equity has changed by -0.76% (-1.12%)